ASK REDCHAT ANYTHING ABOUT AURA BIOSCIENCES, INC.
Aura Biosciences, Inc. (NASDAQ: AURA)
Listen to this Section
$6.57
-0.2260
(
-3.32% )
182.7K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Belzupacap Sarotalocan (Bel-sar)DetailsPrimary Choroidal Melanoma |
Phase 3 |
| Belzupacap Sarotalocan (Bel-sar) (Suprachoroidal (SC) Administration)DetailsPrimary Choroidal Melanoma |
Phase 2 |
| Belzupacap Sarotalocan (Bel-sar)DetailsNon-muscle invasive bladder cancer, Muscle-invasive bladder cancer |
Phase 1 |
Market Data
|
| Open |
$6.57 |
| Previous Close |
$6.80 |
| Volume |
182.7K |
| Market Cap |
$711.30M |
| Day Range |
$6.56 - $6.89 |
| 52 Week Range |
$4.73 - $9.54 |
| Shares Outstanding |
103.39M |
| Change % |
-3.32% |
| Net Change |
▼ -0.2260 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
1,151,132.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-05-20 |
Buy |
50000.00 |
Gibney Anthony S |
| 2025-05-20 |
Buy |
20000.00 |
Johnson David Michael |
| 2024-06-24 |
Sale |
-10500.00 |
Mattessich Antony C. |
| 2024-06-24 |
Sale |
-10500.00 |
Srivastava Sapna |
| 2024-06-24 |
Sale |
-10500.00 |
Johnson David Michael |
| 2024-04-04 |
Sale |
-96000.00 |
Kilroy Conor |
| 2024-02-02 |
Sale |
-71285.00 |
Feder Julie B |
| 2024-02-02 |
Sale |
-28515.00 |
Hopkins Janet Jill |
| 2024-02-02 |
Sale |
-162935.00 |
de los Pinos Elisabet |
| 2024-01-24 |
Sale |
-6609.00 |
Feder Julie B |